BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 34828396)

  • 1. Applications of CRISPR-Cas Technologies to Proteomics.
    Dolgalev G; Poverennaya E
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
    Zhang D; Li Z; Li JF
    J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Nucleotide Editing Technologies for Microbial Metabolic Engineering.
    Arazoe T; Kondo A; Nishida K
    Biotechnol J; 2018 Sep; 13(9):e1700596. PubMed ID: 29862665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR/Cas Systems towards Next-Generation Biosensing.
    Li Y; Li S; Wang J; Liu G
    Trends Biotechnol; 2019 Jul; 37(7):730-743. PubMed ID: 30654914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas for genome editing: Classification, mechanism, designing and applications.
    Bhatia S; Pooja ; Yadav SK
    Int J Biol Macromol; 2023 May; 238():124054. PubMed ID: 36933595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
    Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
    Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-Targeting CRISPR-Cas Systems and Their Applications.
    Burmistrz M; Krakowski K; Krawczyk-Balska A
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR/Cas: A powerful tool for gene function study and crop improvement.
    Zhang D; Zhang Z; Unver T; Zhang B
    J Adv Res; 2021 Mar; 29():207-221. PubMed ID: 33842017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex genome editing of microorganisms using CRISPR-Cas.
    Adiego-Pérez B; Randazzo P; Daran JM; Verwaal R; Roubos JA; Daran-Lapujade P; van der Oost J
    FEMS Microbiol Lett; 2019 Apr; 366(8):. PubMed ID: 31087001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Trend of CRISPR-Based Technologies in COVID-19 Disease: Beyond Genome Editing.
    Najafabadi ZY; Fanuel S; Falak R; Kaboli S; Kardar GA
    Mol Biotechnol; 2023 Feb; 65(2):146-161. PubMed ID: 35091986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversification of the CRISPR Toolbox: Applications of CRISPR-Cas Systems Beyond Genome Editing.
    Balderston S; Clouse G; Ripoll JJ; Pratt GK; Gasiunas G; Bock JO; Bennett EP; Aran K
    CRISPR J; 2021 Jun; 4(3):400-415. PubMed ID: 34152221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in CRISPR technologies for genome editing.
    Song M; Koo T
    Arch Pharm Res; 2021 Jun; 44(6):537-552. PubMed ID: 34164771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome Editing with CRISPR-Cas9: Can It Get Any Better?
    Haeussler M; Concordet JP
    J Genet Genomics; 2016 May; 43(5):239-50. PubMed ID: 27210042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
    Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
    J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas systems: ushering in the new genome editing era.
    Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
    Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of CRISPR/Cas Systems for Precise Genome Editing.
    Hryhorowicz M; Lipiński D; Zeyland J
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of Genome Editing and Transcriptional Control Capabilities Reveals Hierarchies among Diverse CRISPR/Cas Systems in Human Cells.
    Escobar M; Li J; Patel A; Liu S; Xu Q; Hilton IB
    ACS Synth Biol; 2022 Oct; 11(10):3239-3250. PubMed ID: 36162812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas systems: opportunities and challenges for crop breeding.
    Biswas S; Zhang D; Shi J
    Plant Cell Rep; 2021 Jun; 40(6):979-998. PubMed ID: 33977326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.